Medicines, 2014
Shortlist up to four to read them side by side.
1,562 medicine recalls FDA’s Enforcement Report published in 2014, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,562of 1,562 medicine recallsshown with your filters
The list
- Medicine recall ACYCLOVIR, Tablet, 800 mg Labeling: Label Mixup: ACYCLOVIR, Tablet, 800 mg may have potentially been mislabeled as the following drug: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall TERBUTALINE SULFATE, Tablet, 2.5 mg Labeling: Label Mixup: TERBUTALINE SULFATE, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: SOTALOL HCL, Tablet, 80 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall FENOFIBRATE, Tablet, 54 mg Labeling: Label Mixup: FENOFIBRATE, Tablet, 54 mg may have potentially been mislabeled as the following drug: FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DIGOXIN, Tablet, 0.125 mg Labeling: Label Mixup: DIGOXIN, Tablet, 0.125 mg may have potentially been mislabeled as one of the following drugs: MELATONIN, Tablet, 3 mg, NDC 08770140813,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NICOTINE POLACRILEX, LOZENGE, 2 mg Labeling: Label Mixup: NICOTINE POLACRILEX, LOZENGE, 2 mg may have potentially been mislabeled as one of the following drugs: ESTRADIOL, Tablet, 0.5 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall CapsuleTOPRIL, Tablet, 12.5 mg Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 12.5 mg may have potentially been mislabeled as the following drug:, CALCITRIOL, Capsule, 0.25 mcg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall CapsuleTOPRIL, Tablet, 6.25 mg Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 6.25 mg (1/2 of 12.5 mg) may have potentially been mislabeled as the following drug:, LUBIPROSTONE, Capsule, 24… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall CapsuleTOPRIL, Tablet, 25 mg Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 25 mg may have potentially been mislabeled as the following drug: DULoxetine HCl DR, Capsule, 20 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall METHOCARBAMOL, Tablet, 500 mg Labeling: Label Mixup: METHOCARBAMOL, Tablet, 500 mg may have potentially been mislabeled as the following drug: LOSARTAN POTASSIUM, Tablet, 25 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DOXYCYCLINE HYCLATE, Capsule, 100 mg Labeling: Label Mixup: DOXYCYCLINE HYCLATE, Capsule, 100 mg may have potentially been mislabeled as the following drug: RALOXIFENE HCL, Tablet, 60 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall REPAGLINIDE, Tablet, 1 mg Labeling: Label Mixup: REPAGLINIDE, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs: VALSARTAN, Tablet, 40 mg, NDC 00078042315,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall REPAGLINIDE, Tablet, 2 mg Labeling: Label Mixup: REPAGLINIDE, Tablet, 2 mg may have potentially been mislabeled as one of the following drugs: COLCHICINE, Tablet, 0.6 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ANAGRELIDE HCL, Capsule, 0.5 mg Labeling: Label Mixup: ANAGRELIDE HCL, Capsule, 0.5 mg may have potentially been mislabeled as the following drug: ARIPiprazole, Tablet, 2 mg, NDC 59148000613,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall FLUCONAZOLE, Tablet, 200 mg Labeling: Label Mixup: FLUCONAZOLE, Tablet, 200 mg may have potentially been mislabeled as one of the following drugs: VALSARTAN, Tablet, 80 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DUTASTERIDE, Capsule, 0.5 mg Labeling: Label Mixup: DUTASTERIDE, Capsule, 0.5 mg may have potentially been mislabeled as one of the following drugs: DOCUSATE SODIUM, Capsule, 250 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DUTASTERIDE, Capsule, 0.5 mg Labeling: Label Mixup: DUTASTERIDE, Capsule, 0.5 mg may have potentially been mislabeled as one of the following drugs: PHENOL, LOZENGE, 29 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg, Over The Counter Labeling: Label Mixup: OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg may have potentially been mislabeled as one of the following drugs: SEVELAMER CARBONATE,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ASPIRIN DR EC, Tablet, 81 mg, Over The Counter Labeling: Label Mixup: ASPIRIN DR EC, Tablet, 81 mg may have potentially been mislabeled as one of the following drugs: SOTALOL HCL, Tablet, 120 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall SENNOSIDES, Tablet, 8.6 mg, Over The Counter Labeling: Label Mixup: SENNOSIDES, Tablet, 8.6 mg may have potentially been mislabeled as one of the following drugs: FEXOFENADINE HCL, Tablet, 180 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall MIDODRINE HCL, Tablet, 2.5 mg Labeling: Label Mixup: MIDODRINE HCL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: PIOGLITAZONE HCL, Tablet, 15 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall FOSINOPRIL SODIUM, Tablet, 10 mg Labeling: Label Mixup: FOSINOPRIL SODIUM, Tablet, 10 mg may have potentially been mislabeled as the following drug: MERCapsuleTOPURINE, Tablet, 50 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LOVASTATIN, Tablet, 20 mg Labeling: Label Mixup: LOVASTATIN, Tablet, 20 mg may have potentially been mislabeled as one of the following drugs: ASPIRIN EC DR, Tablet, 81 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NABUMETONE, Tablet, 500 mg Labeling: Label Mixup: NABUMETONE, Tablet, 500 mg may have potentially been mislabeled as the following drug: guaiFENesin ER, Tablet, 600 mg, NDC 63824000834,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall CILOSTAZOL, Tablet, 100 mg Labeling: Label Mixup: CILOSTAZOL, Tablet, 100 mg may have potentially been mislabeled as the following drug: TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall CANDESARTAN CILEXETIL, Tablet, 16 mg Labeling: Label Mixup: CANDESARTAN CILEXETIL, Tablet, 16 mg may have potentially been mislabeled as the following drug: IRBESARTAN, Tablet, 150 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall SODIUM CHLORIDE, Tablet, 1 mg, Over The Counter Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs: BISACODYL EC, Tablet, 5 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall GABAPENTIN, Tablet, 600 mg Labeling: Label Mixup: GABAPENTIN, Tablet, 600 mg may have potentially been mislabeled as the following drug: ARIPiprazole, Tablet, 15 mg, NDC 59148000913,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall PROPRANOLOL HCL ER, Capsule, 60 mg Labeling: Label Mixup: PROPRANOLOL HCL ER, Capsule, 60 mg may have potentially been mislabeled as the following drug: CINACALCET HCL, Tablet, 30 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg Labeling: Label Mixup: HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg may have potentially been mislabeled as one of the following drugs: hydrALAZINE HCl, Tablet, 100… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ROSUVASTATIN CALCIUM, Tablet, 5 mg Labeling: Label Mixup: ROSUVASTATIN CALCIUM, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: IBUPROFEN, Tablet, 400 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall METOPROLOL TARTRATE, Tablet, 25 mg Labeling: Label Mixup: METOPROLOL TARTRATE, Tablet, 25 mg may have potentially been mislabeled as the following drug: DOCUSATE SODIUM, Capsule, 250 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall CHLORTHALIDONE, Tablet, 50 mg Labeling: Label Mixup: CHLORTHALIDONE, Tablet, 50 mg may have potentially been mislabeled as the following drug: SENNOSIDES, Tablet, 8.6 mg, NDC 00182109301,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall CHLORTHALIDONE, Tablet, 12.5 mg Labeling: Label Mixup: CHLORTHALIDONE, Tablet, 12.5 mg (1/2 of 25 mg) may have potentially been mislabeled as the following drug: PROPRANOLOL HCL, Tablet, 5 mg… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg Labeling: Label Mixup: ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg may have potentially been mislabeled as the following drug: CYANOCOBALAMIN,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall THIORIDAZINE HCL, Tablet, 50 mg Labeling: Label Mixup: THIORIDAZINE HCL, Tablet, 50 mg may have potentially been mislabeled as the following drug: guanFACINE HCl, Tablet, 1 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall tiZANidine HCl, Tablet, 2 mg Labeling: Label Mixup: tiZANidine HCl, Tablet, 2 mg may have potentially been mislabeled as the following drug: NIACIN TR, Tablet, 500 mg, NDC 00904434260,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall THIOTHIXENE, Capsule, 1 mg Labeling: Label Mixup: THIOTHIXENE, Capsule, 1 mg may have potentially been mislabeled as the following drug: OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall guanFACINE HC, Tablet, 1 mg Labeling: Label Mixup: guanFACINE HC, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs: glyBURIDE, Tablet, 2.5 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mg Labeling: Label Mixup: TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mg may have potentially been mislabeled as the following drug: CAFFEINE, Tablet, 100 mg (1/2 of 200… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LEVOTHYROXINE SODIUM, Tablet, 88 mcg Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 88 mcg may have potentially been mislabeled as one of the following drugs: NEBIVOLOL HCL, Tablet, 5 mg,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LEVOTHYROXINE SODIUM, Tablet, 112 mcg Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as one of the following drugs: ZINC SULFATE, Capsule, 220 mg… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LEVOTHYROXINE SODIUM, Tablet, 175 mcg Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 175 mcg may have potentially been mislabeled as the following drug: PRAMIPEXOLE DI-HCL, Tablet, 1 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ATORVASTATIN CALCIUM, Tablet, 10 mg Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 10 mg may have potentially been mislabeled as one of the following drugs: PANCRELIPASE DR, Capsule, 12000… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ATORVASTATIN CALCIUM, Tablet, 20 mg Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 20 mg may have potentially been mislabeled as one of the following drugs: COENZYME Q-10, Capsule, 100 mg,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ATORVASTATIN CALCIUM, Tablet, 40 mg Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs: ATORVASTATIN CALCIUM, Tablet, 10… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ATORVASTATIN CALCIUM, Tablet, 80 mg Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs: OMEGA-3 FATTY ACID, Capsule,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall MYCOPHENOLATE MOFETIL, Capsule, 250 mg Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Capsule, 250 mg may have potentially been mislabeled as the following drug: PRAMIPEXOLE DI-HCL, Tablet, 0.25 mg,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall TEMAZEPAM, Capsule, 7.5 mg Labeling: Label Mixup: TEMAZEPAM, Capsule, 7.5 mg may have potentially been mislabeled as one of the following drugs: CALCIUM CITRATE, Tablet, 200 mg Elemental… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.